EXOKĒRYX
Biotechnology Research • 
10055 Barnes Canyon Rd, 4th Floor, United States • 21-50 Employees
Company overview
| Headquarters | 10055 Barnes Canyon Rd, 4th Floor, San Diego, California 92121, US |
| Website | |
| NAICS | 541714 |
| Founded | 2021 |
| Employees | 21-50 |
| Socials |
Key Contacts at EXOKĒRYX
Amber Murray
Founder & Svp, Application
Janet Anna
Head Of Product Management
Tyler Harris
Senior Director Of Core Technology
EXOKĒRYX Email Formats
EXOKĒRYX uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@exokeryx.com), used 52.2% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@exokeryx.com | 52.2% |
{first initial}.{last name} | j.doe@exokeryx.com | 34.8% |
{first initial} | j@exokeryx.com | 13% |
About EXOKĒRYX
Powering EV research to realize earlier disease detection. We're speeding up the fight against cancer and other diseases by putting our breakthrough technology in the hands of leading researchers. Today’s diagnostic methods are not good enough. They catch cancer and other diseases too late. Research has begun a focus on Extracellular Vesicles (EVs) for answers to earlier disease detection, diagnosis, and therapies. EVs drive inter-cellular communication within our bodies and hold a key to earlier disease detection. Researchers need advanced technologies to simplify and reproducibly accelerate the exploitation of EVs for discovery of highly sensitive techniques for disease detection and diagnosis. EXOKĒRYX is leveraging semiconductor technology to power best-in-class tools for isolation, characterization, and analysis of extracellular vesicles. Our product roadmap includes automated chip-based technology that leverages dielectorphoresis to isolate EVs with higher recovery and purity. Decoding Extracellular Vesicle biomarkers will allow researchers to define unique fingerprints for earlier disease and cancer detection. Ultimately, powered by our chip-based sensor, we will deliver solutions with the sensitivity and affordability necessary to make it possible for everyone to be tested yearly for cancer and other diseases. Together with researchers, we can drive discovery, detect cancer earlier, and save lives.
EXOKĒRYX revenue & valuation
| Annual revenue | $2,652,205 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $8,500,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
EXOKĒRYX has 15 employees across 7 departments.
Departments
Number of employees
Funding Data
EXOKĒRYX has never raised funding before.
EXOKĒRYX Tech Stack
Discover the technologies and tools that power EXOKĒRYX's digital infrastructure, from frameworks to analytics platforms.
Security
CMS
CDN
Advertising
Analytics
Webmail
Miscellaneous
Security
Authentication
PaaS
Germany
Portugal
United Kingdom
Frequently asked questions
4.8
40,000 users
